The DOI matches its Crossref record.
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Autoimmune chronic spontaneous urticaria: What we know and what we do not know
Kolkhir, P., Church, M. K., Weller, K., Metz, M., Schmetzer, O., & Maurer, M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.050 · Cited by 350
Self-citationAutoimmune chronic spontaneous urticaria
Kolkhir, P., Muñoz, M., Asero, R., Ferrer, M., Kocatürk, E., Metz, M., Xiang, Y.-K., & Maurer, M. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.04.010 · Cited by 301
Self-citationThe role and relevance of mast cells in urticaria
Church, M. K., Kolkhir, P., Metz, M., & Maurer, M. (2018) · Immunological Reviews · doi:10.1111/imr.12632 · Cited by 295
Self-citationMechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria
Kaplan, A. P., Giménez-Arnau, A. M., & Saini, S. S. (2017) · Allergy · doi:10.1111/all.13083 · Cited by 293
Maurer, M., Metz, M., Brehler, R., Hillen, U., Jakob, T., Mahler, V., Pföhler, C., Staubach, P., Treudler, R., Wedi, B., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.032 · Cited by 270
Self-citationAsthma phenotypes and IgE responses
Froidure, A., Mouthuy, J., Durham, S. R., Chanez, P., Sibille, Y., & Pilette, C. (2016) · European Respiratory Journal · doi:10.1183/13993003.01824-2014 · Cited by 267
Broesby‐Olsen, S., Vestergaard, H., Mortz, C. G., Jensen, B., Havelund, T., Hermann, A. P., Siebenhaar, F., Møller, M. B., Kristensen, T. K., Bindslev‐Jensen, C., et al. (2018) · Allergy · doi:10.1111/all.13237 · Cited by 112
“However, also in CSU, around 10% of patients obtain a slower response to therapy, and it is possible that omalizumab acts in several ways to stabilize MC reactivity and mediator release.(23) In addition, the underlying pathophysiology differs in many ways between CSU and SM.”
BackgroundOmalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS
Lemal, R., Fouquet, G., Terriou, L., Vaes, M., Livideanu, C. B., Frenzel, L., Barete, S., Canioni, D., Lhermitte, L., Rossignol, J., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.03.039 · Cited by 70
Treating IgE‐mediated diseases via targeting IgE‐expressing B cells using an anti‐CεmX antibody
Liour, S. S., Tom, A., Chan, Y., & Chang, T. W. (2016) · Pediatric Allergy and Immunology · doi:10.1111/pai.12584 · Cited by 26
Self-citationEfficacy of Omalizumab in Indolent Systemic Mastocytosis
Slapnicar, C., Trinkaus, M., Hicks, L., & Vadas, P. (2019) · Case Reports in Hematology · doi:10.1155/2019/3787586 · Cited by 16
Metadata
- Authors
- Chang, T. W., Chen, C., Lin, C.-J., Metz, M., Church, M. K., & Maurer, M.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 135
- Issue
- 2
- Pages
- 337-342.e2
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2007754697
- Cited by
- 242
- References
- 0
- FWCI
- 24.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.